Exponent sees Q3 EBITDA 26.75%-27.5% of revenues before reimbursements

“Our ability to strategically manage resources with market demand drove 75% utilization in the first half of 2024 and significantly expanded net income and EBITDA1 margin. Considering our encouraging performance in the first half of 2024 and our outlook for the remainder of the year, we are raising full year guidance. Both our previous and updated outlook include the impact of an additional week in the fourth quarter of fiscal 2024,” stated Richard Schlenker, Executive Vice President and Chief Financial Officer…For the third quarter of 2024, as compared to the same period one year prior, Exponent anticipates: Revenues before reimbursements to be approximately flat; and, EBITDA to be 26.75% to 27.5% of revenues before reimbursements. EBITDA to be 26.75% to 27.5% of revenues